Procter & Gamble Company (PG) Q4 2025 Financial Results Summary

# The Procter & Gamble Company (PG) Q4 2025 Financial Results Summary

**Release Date:** July 29, 2025

The Procter & Gamble Company (NYSE: PG) announced its fourth quarter and fiscal year 2025 results, highlighting continued growth in a challenging environment. Here is a summary of the key financial metrics and developments from the report.

### Fiscal Year 2025 Highlights
– **Net Sales:** $84.3 billion
– **Change:** Unchanged vs. FY 2024
– **Organic Sales:** Increased by **2%** (compared to the prior fiscal year)
– **Diluted EPS:** $6.51
– **Change:** Increased by **8%** vs. FY 2024
– **Core EPS:** $6.83
– **Change:** Increased by **4%** vs. FY 2024

### Q4 2025 Highlights
– **Net Sales:** $20.9 billion
– **Change:** Increased by **2%** vs. Q4 2024
– **Organic Sales:** Increased by **2%**
– **Diluted EPS:** $1.48
– **Change:** Increased by **17%** vs. Q4 2024
– **Core EPS:** $1.48
– **Change:** Increased by **6%** vs. Q4 2024

### Cash Flow & Shareholder Returns
– **Operating Cash Flow for FY 2025:** $17.8 billion
– **Net Earnings for FY 2025:** $16.1 billion
– **Adjusted Free Cash Flow Productivity:** **87%**
– **Total Return to Shareholders:** Over $16 billion
– **Dividends Paid:** $9.9 billion (an increase of **5%** from the previous year)
– **Share Repurchases:** $6.5 billion
– **Dividends and Share Repurchase Milestone:**
– Marked the **69th consecutive year** of dividend increases and the **135th consecutive year** of dividend payments.

### Segment Performance Overview (Q4 2025)
– **Beauty Segment:**
– **Organic Sales:** Increased by **1%**
– **Grooming Segment:**
– **Organic Sales:** Increased by **1%**
– **Health Care Segment:**
– **Organic Sales:** Increased by **2%**
– **Fabric & Home Care Segment:**
– **Organic Sales:** Increased by **1%**
– **Baby, Feminine & Family Care Segment:**
– **Organic Sales:** Increased by **1%**

### Cost Structure
– **Gross Margin:** Decreased by **50 basis points** vs. Q4 2024
– **Core Gross Margin:** Decreased by **70 basis points** vs. Q4 2024
– **SG&A Expenses:** Decreased by **240 basis points** as a percentage of sales

### Forward-Looking Guidance
– **Fiscal Year 2026 Expectation:**
– **Sales Growth:** Projected in the range of **1% to 5%**
– **Organic Sales Growth:** Expected range of flat to **up 4%**
– **Diluted EPS Growth:** Estimated between **3% to 9%**
– **Core EPS Growth:** Expected to be flat to **up 4%**
– **Dividend Payment Anticipation:** Around $10 billion
– **Share Repurchase Estimation:** Approximately $5 billion

### Additional Remarks
– The company plans to continue focusing on a **streamlined product portfolio** and executing a new **productivity and cost structure plan**, particularly in the context of ongoing macroeconomic challenges.
– P&G also completed a **limited market portfolio restructuring** impacting several international markets, aiming to better manage economic volatility.

### Conclusion
The Procter & Gamble Company has demonstrated resilience with its fiscal 2025 results, showcasing sales growth and earnings improvement while committing to shareholder value through dividends and share buybacks. Looking forward, P&G anticipates continued growth amidst challenges posed by the economic landscape.

Here are the extracted tables from the press release:

### Condensed Consolidated Statements of Income
(Amounts in Millions Except Per Share Amounts)

### Condensed Consolidated Balance Sheets
(Amounts in Millions)